Jane Street’s Silexion Therapeutics SLXN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXN
WAM
BP
PK
Jane Street's SLXN Position: Q3 2026 in Review
Jane Street opened a new position in Silexion Therapeutics (SLXN) in Q3 2026: 3,020 shares worth $20.1K. The stake represents ﹤0.01% of the portfolio and ranks #11288 among its holdings.
7 funds tracked by Wall St. Rank hold SLXN as of Q3 2026.
- Jane Street held 3,020 shares of Silexion Therapeutics worth $20.1K as of Q3 2026.
- Silexion Therapeutics was a new Jane Street position in Q3 2026.
- Silexion Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #11288 holding.
- 7 funds tracked by Wall St. Rank held Silexion Therapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.